VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
203 hedge funds and large institutions have $1.29B invested in Meridian Bioscience Inc in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 61
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
203
Holding in Top 10
3
Calls
$3.7M
Puts
$2.12M
Top Buyers
| 1 | +$70.9M | |
| 2 | +$33M | |
| 3 | +$23.5M | |
| 4 |
Millennium Management
New York
|
+$23.1M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$19.4M |
Top Sellers
| 1 | -$101M | |
| 2 | -$54.7M | |
| 3 | -$47.6M | |
| 4 |
IC
Impactive Capital
New York City,
New York
|
-$45.3M |
| 5 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
-$40.6M |